RxDoctor Payments DataLook up a doctor →

Gregory Phillips, MD

Interventional Pain Medicine · Eugene, ORNPI 1033319124

Payments from drug & device makers

$2,085,367in general payments, 2019–2025

Across 1,056 payments — averaging $1974.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2M
  • Abbott$79K
  • Medtronic$10K
  • Vertos Medical, Inc.$9K
  • Biotronik Inc.$5K
  • Painteq LLC$4K
  • plus $13K from 25 others
$6,138in research payments, 2019–2025

Across 3 payments — averaging $2045.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$5K
  • Flowonix Medical Incorporated$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,085,367 in reported general payments places this provider in the 95th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$198,230
Medicare patients
342
Services billed
4,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →